Hainan Jinrui Pharmaceutical Co., Ltd.

1. To observe the pharmacokinetic characteristics of the test and reference montelukast sodium chewable tablets after a single oral administration in Chinese healthy subjects in the fasting/postprandial state, and to evaluate the bioequivalence of the two preparations in the fasting/postprandial state. 2. To observe the safety of the test and reference montelukast sodium chewable tablets in Chinese healthy subjects.

The main purpose of the study is to investigate the pharmacokinetic characteristics of a single oral dose of the test preparation Pregabalin Capsules and the reference preparation Pregabalin Capsules (trade name: Lyrica®) under fasting and postprandial conditions, and to evaluate the bioequivalence between the two preparations. The secondary purpose of the study is to observe the safety of the test preparation Pregabalin Capsules and the reference preparation Pregabalin Capsules (trade name: Lyrica®) in healthy subjects.

Primary objective: To observe the pharmacokinetic characteristics of the test preparation voriconazole tablets and the reference preparation voriconazole tablets (trade name: VFEND ®) after a single oral administration in Chinese healthy volunteers in the fasting state, and to evaluate the bioequivalence of the two preparations in the fasting state. Secondary objective: To observe the safety of the test preparation voriconazole tablets and the reference preparation voriconazole tablets in Chinese healthy volunteers.